MedicNest.euLive Grid

bt_bb_section_bottom_section_coverage_image

Dates: 01/07/2022 30/06/2027 Topic: Biomarkers identification Project type: Preclinic Project target: Liver cancer Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE THE UNIVERSITY OF TEXAS SYSTEM Keywords: liver cancer; oncology; tumour; cihrosis; biomarker; hepatology; HCC; claudin-1; Countries: France; USA Project...

Dates: 01/01/2021 31/12/2025 Topic: Tool Project type: Preclinic Immunotherapy Theranostic Project target: Skin Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: WEIZMANN INSTITUTE OF SCIENCE Keywords: oncology; melanoma; tumour; protein; immunotherapy; Itme; microenviroment; machine learning; platform Countries: Israel Project page: Access page  

Dates: 01/10/2020 31/12/2024 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Cervical Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: STICHTING VUMC Keywords: screening; cervical cancer; tumour; HPV; cytology; DNA; e-health; vaccine; clinical trial Countries: Netherlands; Sweden; France; Finland; Spain; Belgium; Slovenia;...

Dates: 01/12/2020 30/11/2025 Topic: Biomarkers identification Project type: Preclinic Theranostic Project target: Skin Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III Keywords: melanoma; tumour; mice; surgery; immunology; metastases; metAlert; bioluminiscence Countries: Spain Project page: Access page  

Dates: 01/04/2020 31/03/2025 Topic: Biomarkers identification Project type: Immunotherapy Preclinic Clinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSITY OF CYPRUS Keywords: biomarker; oncology; tumour; immunotherapy; model; biomechanic Countries: Cyprus Project page: Access page  

Dates: 01/01/2021 31/12/2025 Topic: Biomarkers identification AI/Big data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Keywords: Prostate cancer; colorectal cancer; drug resistance; reinforcement; tumour; biomarker; HTS; QSAR; monotherapy Countries: Germany Project page: Access...

Dates: 01/05/2021 30/04/2026 Topic: Biomarkers identification Project type: Preclinic Theranostic Project target: Digestive disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Keywords: cachexia; cancer; tumour; biomarker; adipocyte; adipose tissue; OMICs; metabolism; glucose; lipid Countries: Germany Project page: Access page  

Dates: 01//02/2020 31/01/2025 Topic: Biomarkers identification Tool Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSIDADE NOVA DE LISBOA Keywords: nanotechnology; cancer; nanohydrogels; platform; tumour; RNA; nano-material Countries: Portugal Project page: Access page  

Dates: 01/07/2018 30/06/2025 Topic: Biomarkers identification Project type: Clinic Project target: Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: KOBENHAVNS UNIVERSITET Keywords: Acrylamide; toxicity; children; women; prenatal; obstetric; robotic; neurology; nutrition; tumour; mutation; growth Countries: Denmark; Sweden Project page: Access page  

Dates: 01/01/2019 31/05/2023 Topic: Tool AI/Big Data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5.3. – Using in-silico medicine for improving disease management and prediction Other Participating agents: TECHNIKON FORSCHUNGS- UND PLANUNGSGESELLSCHAFT MBH Keywords: paediatric; oncology; big data; cancer; machine learning; stadistics; tumour; clinical...